BioTech After Hours Active Stocks: Regeneron (NASDAQ:REGN), Ambarella (NASDAQ:AMBA), Progress Software (NASDAQ:PRGS)

In a note issued Friday, Piper Jaffray said the weakness in Regeneron (NASDAQ:REGN) is a buying opportunity, as the firm sees risks to the company’s alirocumab Phase III program as overblown, with neither Regeneron  (NASDAQ:REGN) or its development partner Sanofi (SNY) having seen any neurocognitive adverse events with the drug. The firm reiterates a Buy rating…

Read More

Large Caps in Focus: Goodyear Tire & Rubber (NASDAQ:GT), Verizon Communications (NYSE:VZ), Bed Bath & Beyond Inc. (NASDAQ:BBBY), Dun & Bradstreet Corp. (NYSE:DNB)

Shares of Goodyear Tire & Rubber (NASDAQ:GT) are nudging higher in Friday’s evening trade as the company declares the final quarterly dividend on the company’s 5.875% mandatory convertible preferred stock, which is subject to mandatory conversion into shares of Goodyear (NASDAQ:GT) common stock on April 1, 2014. The tire company’s dividend of $0.73 per share…

Read More

Landstar (NASDAQ:LSTR) Provides Encouraging Guidance

In an analyst note published by Matthew Young at Morningstar, he broke down Landstar System Inc’s (NASDAQ:LSTR) encouraging management guidance update.  Management expects Q1 revenues in the $640-690 million range, within the Street consensus of $.59. Some of the other note highlights are included below: Landstar provided an encouraging mid-first-quarter guidance update–freight demand continues to…

Read More

NASDAQ Bullish Stocks: Smith Micro Software (NASDAQ:SMSI), Skullcandy Inc. (NASDAQ:SKUL), FuelCell Energy (NASDAQ:FCEL), Hurco Companies Inc. (NASDAQ:HURC)

Shares of headphone maker Skullcandy Inc. (NASDAQ:SKUL) extended pre-market gains and hit a 52-week high of $11.40 in recent early trade after the company reported Q4 earnings and Q1 guidance that beat street expectations. The shares were slightly off their earlier highs by mid-morning, but were nevertheless up 42.5% at $10.59. Also this morning, Northland…

Read More

Tech News

Tech Analysis & Market News

Skip to content ↓